iSpecimen (NASDAQ:ISPC) just reported results for the first quarter of 2024.
- iSpecimen reported earnings per share of -32 cents. This was below the analyst estimate for EPS of -27 cents.
- The company reported revenue of $2.29 million.
- This was 19.37% worse than the analyst estimate for revenue of $2.84 million.